XML 34 R22.htm IDEA: XBRL DOCUMENT
v3.21.2

Share-based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2021
Share-based Payment Arrangement [Abstract] |
Share-based Compensation | 14. Share-based Compensation Total share-based compensation expense recognized by the Company and its subsidiaries under all equity compensation arrangements was $1.1 million and $1.5 million for the six months ended June 30, 2021 and 2020, respectively. All grants are time based and vest either immediately or over a period established at grant. The Company recognizes compensation expense for equity awards, reduced by actual forfeitures, using the straight-line basis. Restricted Stock A summary of HC2’s restricted stock activity is as follows:
|  | Shares |  | Weighted Average Grant Date Fair Value
Unvested - December 31, 2019 |  | 2,213,775 |  |  | $ | 5.12 |
Granted |  | 1,152,202 |  |  | $ | 2.74 |
Vested |  | (2,258,905) |  |  | $ | 4.08 |
Forfeited |  | (478,639) |  |  | $ | 5.87 |
Unvested - December 31, 2020 |  | 628,433 |  |  | $ | 3.93 |
Granted |  | 593,458 |  |  | $ | 3.81 |
Vested |  | (425,222) |  |  | $ | 3.74 |
Forfeited |  | (31,171) |  |  | $ | 2.62 |
Unvested - June 30, 2021 |  | 765,498 |  |  | $ | 4.00 |
At June 30, 2021, the total unrecognized stock-based compensation expense related to unvested restricted stock was $2.0 million. The unrecognized compensation cost is expected to be recognized over the remaining weighted average period of 2.2 years. Stock Options A summary of HC2’s stock option activity is as follows:
|  | Shares |  | Weighted Average Exercise Price
Outstanding - December 31, 2019 |  | 7,067,592 |  |  | $ | 6.52 |
Granted |  | 143,096 |  |  | $ | 2.62 |
Exercised |  | — |  |  | $ | — |
Forfeited |  | (142,503) |  |  | $ | 5.45 |
Expired |  | (2,328,327) |  |  | $ | 9.18 |
Outstanding - December 31, 2020 |  | 4,739,858 |  |  | $ | 5.13 |
Granted |  | — |  |  | $ | — |
Exercised |  | — |  |  | $ | — |
Forfeited |  | — |  |  | $ | — |
Expired |  | (21,599) |  |  | $ | 5.45 |
Outstanding - June 30, 2021 |  | 4,718,259 |  |  | $ | 5.13 |
Eligible for exercise |  | 4,716,909 |  |  | $ | 5.13 |
At June 30, 2021, the intrinsic value and average remaining life of the Company's outstanding options were $0.2 million and approximately 3.1 years, and intrinsic value and average remaining life of the Company's exercisable options were $0.2 million and approximately 3.1 years. At June 30, 2021, the total unrecognized stock-based compensation expense related to unvested stock options was $0.1 million. The unrecognized compensation cost is expected to be recognized over the remaining weighted average period of 0.7 years. There are 1,350 unvested stock options expected to vest, with a weighted average remaining life of 7.7 years, a weighted average exercise price of $2.62, and an intrinsic value of $0.1 million.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration